AU2849600A - Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists - Google Patents

Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists

Info

Publication number
AU2849600A
AU2849600A AU28496/00A AU2849600A AU2849600A AU 2849600 A AU2849600 A AU 2849600A AU 28496/00 A AU28496/00 A AU 28496/00A AU 2849600 A AU2849600 A AU 2849600A AU 2849600 A AU2849600 A AU 2849600A
Authority
AU
Australia
Prior art keywords
pyridobenzoxazepine
pyridobenzodiazepine
carboxyamide
vasopressin agonists
vasopressin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28496/00A
Inventor
Amedeo Arturo Failli
Robert John Steffan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU2849600A publication Critical patent/AU2849600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU28496/00A 1999-02-04 2000-01-13 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists Abandoned AU2849600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24468199A 1999-02-04 1999-02-04
US09244681 1999-02-04
PCT/US2000/000886 WO2000046225A2 (en) 1999-02-04 2000-01-13 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists

Publications (1)

Publication Number Publication Date
AU2849600A true AU2849600A (en) 2000-08-25

Family

ID=22923710

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28496/00A Abandoned AU2849600A (en) 1999-02-04 2000-01-13 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists

Country Status (6)

Country Link
EP (1) EP1149097A2 (en)
JP (1) JP2002536375A (en)
CN (1) CN1339035A (en)
AU (1) AU2849600A (en)
CA (1) CA2358895A1 (en)
WO (1) WO2000046225A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
EP3226690B1 (en) * 2014-12-05 2020-05-20 Merck Sharp & Dohme Corp. Novel tricyclic compounds as inhibitors of mutant idh enzymes
EP3226689B1 (en) * 2014-12-05 2020-01-15 Merck Sharp & Dohme Corp. Novel tricyclic compounds as inhibitors of mutant idh enzymes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849735A (en) * 1995-01-17 1998-12-15 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
PT1000059E (en) * 1997-07-30 2004-12-31 Wyeth Corp VASOPRESSIN TRICYCLIC AGONISTS

Also Published As

Publication number Publication date
CN1339035A (en) 2002-03-06
WO2000046225A2 (en) 2000-08-10
WO2000046225A3 (en) 2000-12-14
JP2002536375A (en) 2002-10-29
CA2358895A1 (en) 2000-08-10
EP1149097A2 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
AU7989400A (en) Compounds and methods
AU6233200A (en) Components and methods for use with explosives
AU5826100A (en) Benzazepinones and quinazolines
AU3215500A (en) Compounds and methods
AU2001253126A1 (en) (+) naloxone and epinephrine combination therapy
AU3620600A (en) Skin-marking devices and their use
AU7065200A (en) Putting improvement devices and methods
AU7073800A (en) Novel plexins and uses thereof
AU1403501A (en) Novel composition and use
AU7659998A (en) N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU2841801A (en) Triazolotriazinones and the use thereof
EP1299410A4 (en) GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
AU1554301A (en) Radioprotecting agent
AU5791799A (en) Xanthine compound preparations and new uses thereof
AU1083501A (en) Antibiotic-metal complex and methods
AUPQ084899A0 (en) Neurotrophin agonists
GB2345816B (en) Combination connector and microphone
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU2849600A (en) Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
AU7615200A (en) Vasopressin agonist formulation and process
AU2312500A (en) Cage former and clamp therefor
AU2136401A (en) P450rai-2 and related proteins
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU5979300A (en) Angiopoietin-6 and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase